Invesco Ltd. Generation Bio Co. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Generation Bio Co. stock. As of the latest transaction made, Invesco Ltd. holds 12,413 shares of GBIO stock, worth $12,661. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,413

Previous 13,352 7.03%

Holding current value

$12,661

Previous $37,000 18.92%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$2.16 - $3.51 $2,028 - $3,295	-939 Reduced 7.03%	12,413 $30,000
Q2 2024 Aug 13, 2024	SELL	$2.64 - $4.35 $5,478 - $9,026	-2,075 Reduced 13.45%	13,352 $37,000
Q1 2024 May 14, 2024	SELL	$1.73 - $4.07 $108,502 - $255,262	-62,718 Reduced 80.26%	15,427 $62,000
Q4 2023 Feb 12, 2024	BUY	$0.91 - $3.35 $3,401 - $12,522	3,738 Added 5.02%	78,145 $128,000
Q3 2023 Nov 13, 2023	BUY	$3.65 - $6.9 $1,868 - $3,532	512 Added 0.69%	74,407 $282,000
Q2 2023 Aug 11, 2023	SELL	$3.5 - $5.67 $2,467 - $3,997	-705 Reduced 0.95%	73,895 $406,000
Q1 2023 May 12, 2023	BUY	$3.61 - $7.01 $209,080 - $405,998	57,917 Added 347.16%	74,600 $320,000
Q4 2022 Feb 13, 2023	SELL	$3.66 - $6.77 $47 - $88	-13 Reduced 0.08%	16,683 $65,000
Q3 2022 Nov 14, 2022	BUY	$4.68 - $8.34 $351 - $625	75 Added 0.45%	16,696 $89,000
Q2 2022 Aug 15, 2022	SELL	$4.87 - $9.41 $12,442 - $24,042	-2,555 Reduced 13.32%	16,621 $110,000
Q1 2022 May 16, 2022	BUY	$4.16 - $7.76 $940 - $1,753	226 Added 1.19%	19,176 $141,000
Q4 2021 Feb 14, 2022	SELL	$5.99 - $24.97 $10,847 - $45,220	-1,811 Reduced 8.72%	18,950 $135,000
Q3 2021 Nov 15, 2021	BUY	$20.0 - $27.43 $61,340 - $84,127	3,067 Added 17.33%	20,761 $521,000
Q2 2021 Aug 17, 2021	BUY	$24.34 - $38.34 $430,671 - $678,387	17,694 New	17,694 $476,000

Others Institutions Holding GBIO

# of Institutions

Shares Held

49.6M

Call Options Held

Put Options Held

View Full List

About Generation Bio Co.

Ticker GBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,011,200
Market Cap $60.2M
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...

More about GBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account